Published in Transplant Proc on February 01, 1995
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87
Fig-eating by vertebrate frugivores: a global review. Biol Rev Camb Philos Soc (2001) 2.65
Liver transplantation across ABO blood groups. Surgery (1986) 2.39
The antibody crossmatch in liver transplantation. Surgery (1986) 2.33
Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11
Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90
Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology (1996) 1.89
Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89
Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation (1995) 1.81
Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation (1989) 1.67
Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol (1993) 1.64
Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62
Liver transplantation for fulminant hepatic failure. Semin Liver Dis (1985) 1.56
Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg (1998) 1.53
Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50
Indications for liver transplantation in the cyclosporine era. Surg Clin North Am (1986) 1.46
Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc (1987) 1.36
OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc (1987) 1.35
Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol (1987) 1.24
Experience with primary liver transplantation across ABO blood groups. Transplant Proc (1987) 1.23
Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer (1988) 1.22
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg (1987) 1.19
MicroRNAs as immune regulators: implications for transplantation. Am J Transplant (2010) 1.16
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation (1995) 1.13
Liver transplantation in patients with patent splenorenal shunts. Surgery (1987) 1.12
Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol (1997) 1.12
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology (1996) 1.11
Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med (1995) 1.11
Adenoviral infections in pediatric liver transplant recipients. JAMA (1987) 1.06
Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc (1985) 1.04
Pulmonary varices presenting as a solitary lung mass in a patient with end-stage liver disease. Chest (1994) 1.03
Adolescent non-adherence: prevalence and consequences in liver transplant recipients. Pediatr Transplant (2006) 1.03
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg (1999) 1.03
Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr (2010) 1.03
Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum Gene Ther (1997) 1.02
Pseudoaneurysms complicating organ transplantation: roles of CT, duplex sonography, and angiography. Radiology (1988) 1.00
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation (1998) 1.00
Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology (1995) 0.99
Torsion of a nongravid myomatous uterus: radiological features and literature review. Hong Kong Med J (2010) 0.98
Differential expression of microRNAs during allograft rejection. Am J Transplant (2012) 0.98
Liver transplantation for treatment of giant hepatocellular adenomas. Liver Transpl Surg (1995) 0.97
Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology (2000) 0.97
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. Transplant Proc (1995) 0.96
Factors affecting survival after orthotopic liver transplantation in infants. Transplantation (1997) 0.96
Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95
Is multiple organ failure a contraindication for liver transplantation in children? Transplant Proc (1987) 0.95
Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation (1987) 0.94
Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg (1996) 0.93
Liver replacement after massive hepatic trauma. J Trauma (1987) 0.92
Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury. Clin Exp Immunol (1989) 0.92
Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty. Radiology (1989) 0.92
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation (1993) 0.91
Allelic variants of ovine prion protein gene (PRNP) in Oklahoma sheep. Cytogenet Genome Res (2003) 0.90
Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis. Semin Liver Dis (1989) 0.90
Differential gene expression in the perichondrium and cartilage of the neonatal mouse temporomandibular joint. Orthod Craniofac Res (2009) 0.90
Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation (2001) 0.90
Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway. J Immunol (2001) 0.90
Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation (1994) 0.90
Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pediatr (1997) 0.90
Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis (1985) 0.89
Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation (1998) 0.89
Liver transplantation in Asian patients with chronic hepatitis B. Hepatology (1997) 0.89
Experimental carotid stenosis due to fibrous intimal hyperplasia. Surg Gynecol Obstet (1981) 0.89
Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting. Bridge to liver transplantation. Transplantation (1996) 0.89
Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation (1995) 0.89
Transcriptome analysis of the salivary glands of the female tick Amblyomma americanum (Acari: Ixodidae). Insect Mol Biol (2009) 0.88
Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome). Transpl Int (1992) 0.88
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver (2001) 0.88
Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol (1996) 0.88
Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation (1995) 0.88
Intragraft cytokine profile during human liver allograft rejection. Transplantation (1992) 0.88